SCHEMBL352889

SCHEMBL352889

CN(Cc1nsc(NC(=O)NCc2ccc(Cl)s2)n1)C(=O)c1n[nH]c(=O)c2ccccc12

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
NR1H4 Q96RI1 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
ALDH1A1 P00352 3/20 0.36
MAPK1 P28482 1/20 0.36
MMP3 P08254 2/20 0.36
HTT P42858 2/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
CYP1A2 P05177 1/20 0.36
LMNA P02545 2/20 0.35
POLB P06746 2/20 0.35
KDM4E B2RXH2 1/20 0.35
TSHR P16473 1/20 0.35
RAB9A P51151 3/20 0.35
NPC1 O15118 2/20 0.35
PTBP1 P26599 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL353624 0.87 KMT2A (0.43) KMT2AMEN1NR1H4L3MBTL1ALDH1A1
SCHEMBL353858 0.85 HTT (0.42) KMT2AMEN1ALDH1A1MAPK1HTT
Phthalazinone SCHEMBL19118752 0.83 ALDH1A1 (0.35) KMT2AMEN1ALDH1A1MMP3HTT
SCHEMBL354016 0.83 L3MBTL1 (0.44) KMT2AMEN1NR1H4L3MBTL1MAPK1
SCHEMBL19119501 0.77 HTT (0.35) ALDH1A1MAPK1HTTSMN1; SMN2LMNA
SCHEMBL352384 0.77 ALDH1A1 (0.37) KMT2AMEN1L3MBTL1ALDH1A1HTT
SCHEMBL353960 0.77 HTT (0.36) KMT2AMEN1ALDH1A1MMP3HTT
SCHEMBL353482 0.76 THRB (0.43) CYP1A2LMNAKDM4E
SCHEMBL352911 0.75 HSD11B1 (0.42) KMT2AMEN1ALDH1A1HTTSMN1; SMN2
SCHEMBL19118740 0.75 ALDH1A1 (0.33) KMT2AMEN1ALDH1A1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148380-B2 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds CRESTONE, INC. (US) 2012-04-03 US claimed
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds CRESTONE, INC. (US) 2012-01-19 US claimed
EP-2200440-A1 ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS Crestone, Inc. (US) 2010-06-30 EP claimed
WO-2009015208-A1 ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS REPLIDYNE, INC. (US) 2009-01-29 WO claimed
US-8148380-B2 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds CRESTONE, INC. (US) 2012-04-03 US disclosed
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds CRESTONE, INC. (US) 2012-01-19 US disclosed
EP-2200440-A1 ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS Crestone, Inc. (US) 2010-06-30 EP disclosed
WO-2009015208-A1 ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS REPLIDYNE, INC. (US) 2009-01-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds NAAA, AADAC, RPSA KMT2A 1210/4885MEN1 4239/4885NR1H4 1890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.